| 摘要 |
Disclosed is a compound represented by Formula 1 e.g. [({ 5-[4-(2-fluoro-5-{ [(2-fluoro-5-methylphenyl)amino]carbonyl} phenoxy)pyridin-2-yl]-1H-pyrrol-3-yl} carbonyl)amino]acetic acid wherein for the treatment of one of the diseases or conditions selected from the group consisting of colorectal cancer, lung cancer, hematological cancer, renal cancer, liver cancer, breast cancer, diabetic retinopathy, macular degeneration, age-related macular degeneration, retinopathy of prematurity, ocular angiogenesis, retinal edema, retinal ischemia, diabetic macular edema, cystoid macular edema, retinal vein occlusion, branch vein occlusion, preretinal neovascularization, laser-induced choroidal neovascularization, neovascularization associated with keratoplasty, glaucoma and ocular tumors, arthritis, restenosis, hepatic cirrhosis, atherosclerosis, psoriasis, diabetes mellitus, wound healing, inflammation, neurodegenerative diseases and immune disorders in the human being. |
